CA2047235A1 - Procede pour le traitement enzymatique de substrats - Google Patents

Procede pour le traitement enzymatique de substrats

Info

Publication number
CA2047235A1
CA2047235A1 CA002047235A CA2047235A CA2047235A1 CA 2047235 A1 CA2047235 A1 CA 2047235A1 CA 002047235 A CA002047235 A CA 002047235A CA 2047235 A CA2047235 A CA 2047235A CA 2047235 A1 CA2047235 A1 CA 2047235A1
Authority
CA
Canada
Prior art keywords
carrier material
binding
fusion protein
binding peptide
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002047235A
Other languages
English (en)
Inventor
Rainer Rudolph
Erhard Kopetzki
Stephan Fischer
Adelbert Grossmann
Barbel Holl-Neugebauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4001508A external-priority patent/DE4001508A1/de
Priority claimed from DE4002636A external-priority patent/DE4002636A1/de
Application filed by Individual filed Critical Individual
Publication of CA2047235A1 publication Critical patent/CA2047235A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
CA002047235A 1990-01-19 1991-01-18 Procede pour le traitement enzymatique de substrats Abandoned CA2047235A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEP4001508.4 1990-01-19
DE4001508A DE4001508A1 (de) 1990-01-19 1990-01-19 Verfahren zur enzymatischen behandlung von substraten
DEP4002636.1 1990-01-30
DE4002636A DE4002636A1 (de) 1990-01-30 1990-01-30 Expression von hiv1- und 2-polypeptiden und deren verwendung

Publications (1)

Publication Number Publication Date
CA2047235A1 true CA2047235A1 (fr) 1991-07-20

Family

ID=25889228

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002047235A Abandoned CA2047235A1 (fr) 1990-01-19 1991-01-18 Procede pour le traitement enzymatique de substrats

Country Status (6)

Country Link
EP (1) EP0464184A1 (fr)
JP (1) JPH04503610A (fr)
KR (1) KR920701822A (fr)
AU (1) AU633686B2 (fr)
CA (1) CA2047235A1 (fr)
WO (1) WO1991010910A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316004B1 (en) * 1993-06-22 2001-11-13 T. Tikhonenko Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the productivity of farm animals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
CA1340522C (fr) * 1987-03-10 1999-05-04 Heinz Dobeli Proteins hybrides renfermant des histidines voisines pour une purification amelioree
DE286239T1 (de) * 1987-03-10 1994-02-24 New England Biolabs Inc Herstellung und Reinigung eines Proteins, das mit einem Bindungsprotein fusioniert ist.
US4921787A (en) * 1987-05-01 1990-05-01 Cambridge Bioscience Corporation Detection of antibodies to human immunodeficiency virus by agglutination of antigen coated latex
AU609241B2 (en) * 1988-01-29 1991-04-26 Abbott Laboratories Ion-capture assays and devices
DE58905660D1 (de) * 1988-04-25 1993-10-28 Hoffmann La Roche Diagnose-Hilfsmittel.
DE3822045A1 (de) * 1988-06-30 1990-01-11 Hoechst Ag Verfahren zur herstellung von proteinen

Also Published As

Publication number Publication date
EP0464184A1 (fr) 1992-01-08
WO1991010910A2 (fr) 1991-07-25
AU633686B2 (en) 1993-02-04
WO1991010910A3 (fr) 1991-10-03
JPH04503610A (ja) 1992-07-02
KR920701822A (ko) 1992-08-12
AU7072491A (en) 1991-08-05

Similar Documents

Publication Publication Date Title
Yaron et al. Expression, purification and subunit-binding properties of cohesins 2 and 3 of the Clostridium thermocellum cellulosome
Morag et al. Expression, purification, and characterization of the cellulose-binding domain of the scaffoldin subunit from the cellulosome of Clostridium thermocellum
US5670623A (en) Methods of use of cellulose binding domain proteins
CN103380213B (zh) 碱性磷酸酶
JPH0634742B2 (ja) 蛋白質とポリペプチドを製造及び分離する方法
FI95046C (fi) Menetelmä lämpöstabiilin sytosiinideaminaasin tuottamiseksi
JPH07508652A (ja) 融合タンパク質の製造によって酵素を微生物細胞の細胞壁に固定化する方法
CN109613240B (zh) 一种用于检测hiv的试剂盒
JPH06500006A (ja) ユビキチン特異的プロテアーゼ
CN103937821B (zh) 一种腈水解酶基因及其原核表达和固定化技术
US7759089B2 (en) Recombinant protein comprising starch binding domain and use thereof
Zhao et al. Purification and immobilization of the soluble and insoluble portions of recombinant lipase by gram-positive enhancer matrix (GEM) particles
CN100557019C (zh) 重组牛肠激酶、其制备方法及用途
CN112646800A (zh) 制备固定化酶或固定化蛋白质的方法以及固定化酶或固定化蛋白质
CA2025929C (fr) Methode d'essais de complementation enzymatique de proteines de liaison
CN115725529B (zh) 一种氟化酶突变体和细胞表面展示氟化酶的微生物细胞及其应用
CA2047235A1 (fr) Procede pour le traitement enzymatique de substrats
US5310876A (en) Expression of HIV1 and HIV2 polypeptides and their use
Allard et al. Versatile method for production and controlled polymer‐immobilization of biologically active recombinant proteins
JPH08512210A (ja) ペプチドの合成及び精製のための方法
WO1997035964A1 (fr) Particules magnetiques fines contenant des proteines utiles auxquelles elles sont liees, procede de production et utilisation de ces particules
AU5664790A (en) Method for protein binding enzyme complementation assays
CN110592119A (zh) 一种来源于类芽孢杆菌新型普鲁兰酶及其基因与应用
JPH0371112B2 (fr)
CN102190730A (zh) 一种生物素蛋白连接酶融合蛋白

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead